JPS56118016A - Long term functional antiarrhythmic drug whose active component is alphaa*22*bis*11 methylethyl*amino*ethyl**alphaaphenyll22 pyridineacetamide or one of salts* its manufacture and composition containi - Google Patents

Long term functional antiarrhythmic drug whose active component is alphaa*22*bis*11 methylethyl*amino*ethyl**alphaaphenyll22 pyridineacetamide or one of salts* its manufacture and composition containi

Info

Publication number
JPS56118016A
JPS56118016A JP17817480A JP17817480A JPS56118016A JP S56118016 A JPS56118016 A JP S56118016A JP 17817480 A JP17817480 A JP 17817480A JP 17817480 A JP17817480 A JP 17817480A JP S56118016 A JPS56118016 A JP S56118016A
Authority
JP
Japan
Prior art keywords
pyridineacetamide
alphaa
methylethyl
bis
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP17817480A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0141606B2 (ko
Inventor
Robaato Buruua Jiyon
Heizu Jiyofuri
Seeru Jiyatsuku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of JPS56118016A publication Critical patent/JPS56118016A/ja
Publication of JPH0141606B2 publication Critical patent/JPH0141606B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
JP17817480A 1979-12-21 1980-12-18 Long term functional antiarrhythmic drug whose active component is alphaa*22*bis*11 methylethyl*amino*ethyl**alphaaphenyll22 pyridineacetamide or one of salts* its manufacture and composition containi Granted JPS56118016A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7931443A FR2471784A1 (fr) 1979-12-21 1979-12-21 Medicaments antiarythmiques a action prolongee dont le principe actif est le a/2-/bis (1-methylethyl) amino/ethyl/-a-phenyl-2-pyridine acetamide ou ses sels, ainsi que le procede de preparation de ces nouveaux medicaments et compositions les renfermant

Publications (2)

Publication Number Publication Date
JPS56118016A true JPS56118016A (en) 1981-09-16
JPH0141606B2 JPH0141606B2 (ko) 1989-09-06

Family

ID=9233075

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17817480A Granted JPS56118016A (en) 1979-12-21 1980-12-18 Long term functional antiarrhythmic drug whose active component is alphaa*22*bis*11 methylethyl*amino*ethyl**alphaaphenyll22 pyridineacetamide or one of salts* its manufacture and composition containi

Country Status (13)

Country Link
JP (1) JPS56118016A (ko)
AU (1) AU543380B2 (ko)
BE (1) BE886774A (ko)
CA (1) CA1151067A (ko)
DE (1) DE3048154A1 (ko)
FR (1) FR2471784A1 (ko)
GB (1) GB2068226B (ko)
IT (1) IT1144024B (ko)
MA (1) MA19021A1 (ko)
NL (1) NL191171C (ko)
PT (1) PT72256B (ko)
SE (1) SE8007640L (ko)
ZA (1) ZA807807B (ko)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08143450A (ja) * 1994-11-14 1996-06-04 Taiyo Yakuhin Kogyo Kk 徐放化製剤
JP2009530258A (ja) * 2006-03-16 2009-08-27 ユーロセルティック ソシエテ アノニム 医薬品球状物

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982004392A1 (en) * 1981-06-18 1982-12-23 Uclaf Roussel Method of preparing pharmaceutical compositions containing alpha-/2-/bis(1-methylethyl)amino/ethyl/alpha-phenyl 2-pyridine acetamide or one of its salts
US4789549A (en) * 1987-03-09 1988-12-06 Warner-Lambert Company Sustained release dosage forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3062720A (en) * 1959-05-20 1962-11-06 Philips Roxane Sustained release pharmaceutical tablet
FR2485M (fr) * 1961-05-17 1964-04-27 Searle & Co Nouveaux régulateurs cardiaques.
GB1021924A (en) * 1962-06-22 1966-03-09 Smith Kline French Lab Improvements in or relating to method of preparing sustained release tablets
BE708434A (ko) * 1966-12-22 1968-05-02

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08143450A (ja) * 1994-11-14 1996-06-04 Taiyo Yakuhin Kogyo Kk 徐放化製剤
JP2009530258A (ja) * 2006-03-16 2009-08-27 ユーロセルティック ソシエテ アノニム 医薬品球状物

Also Published As

Publication number Publication date
PT72256B (fr) 1982-07-15
DE3048154C2 (ko) 1992-03-19
NL191171C (nl) 1995-03-01
NL191171B (nl) 1994-10-03
DE3048154A1 (de) 1981-09-03
ZA807807B (en) 1982-01-27
GB2068226B (en) 1984-03-21
CA1151067A (fr) 1983-08-02
PT72256A (fr) 1981-01-01
SE8007640L (sv) 1981-06-22
IT8050423A0 (it) 1980-12-19
IT1144024B (it) 1986-10-29
NL8006938A (nl) 1981-07-16
AU543380B2 (en) 1985-04-18
GB2068226A (en) 1981-08-12
MA19021A1 (fr) 1981-07-01
FR2471784B1 (ko) 1982-12-17
BE886774A (fr) 1981-06-19
FR2471784A1 (fr) 1981-06-26
AU6560480A (en) 1981-06-25
JPH0141606B2 (ko) 1989-09-06

Similar Documents

Publication Publication Date Title
JPS5359692A (en) Production of novel substituted benzamide and pharmaceutical composition containing same
GR59825B (en) Preparation process of n-(3-trifluormethyl-4-halogen-phenyl)-n'-urea and their use as insecticides
JPS532471A (en) Production of antiibacterial compound and pharmaceutical composition containing same
JPS52111573A (en) 4*55dichlorooimidazolee22 carboxylic acid derivatives * base and salt thereof * composition containing same and use of same*
TR20232A (tr) Cis-9-trikosen ve metomil'den olusan ensektisit bilesim
JPS52105168A (en) Production of 1*22 benzisothiazolinee33ones and use of same as pharmaceutical agent
BE840210A (fr) Composition d'amidon et de polyester
JPS52148038A (en) Production of novel benzamide and pharmaceutical composition containing same
JPS52111553A (en) Novel 177ester of 17 alphaa hydroxygestogene and composition containing same and preparation thereof
JPS56118016A (en) Long term functional antiarrhythmic drug whose active component is alphaa*22*bis*11 methylethyl*amino*ethyl**alphaaphenyll22 pyridineacetamide or one of salts* its manufacture and composition containi
JPS5610166A (en) Novel derivatives of alphaaphenyll22 purrolidineemethanol and salts thereof* these manufacture* application as drug and composition containing them
IL58421A0 (en) Production of (2'-5') oligo-isoadenylate and pharmaceutical compositions containing them
JPS51131888A (en) Production of novel 99 alkylaminooerythromycine and pharmaceutical composition containing same
IL55178A (en) Preparation of n-substituted amides of alpha-ketocarboxylic acids and some such novel amides
BE868590A (fr) Derives alpha-acetyleniques et alpha-vinyliques d'amino-acides
JPS5223010A (en) Preparation and use of 1*11 dichlorr44methyll33hydroxyy bentt11en
GB2053195B (en) Chlorhexidine salts and compositions of same
JPS55160758A (en) Novel derivative of 1 alpha*255 dihydroxycholecalciferol* its manufacture* use as drug and pharmaceutic composition containing it
JPS5673079A (en) Amino derivative of 22methyll55*22hydroxystyryl**1*3*44thiadiazole* its manufacture and medicine containing it
IL47941A (en) Preparation of 6-chloro-2-chloromethyl-4-phenylquinazoline-3-oxide and 2-(1'-chloroimino-2'-chloromethyl)-5-chlorobenzophenone as intermediate thereof
JPS52116437A (en) Preparation and use of pharmaceutical composition comprising novel compound
JPS5353678A (en) Production of novel triazine 2*44dione and pesticide composition containing same as active component
JPS52106855A (en) Novel halogenated derivatives of 16 alphaamethypregnane * preparation thereof and pharmaceutical composition
JPS5337651A (en) Production of novel 2*22 dimethyll199norsteroid and pharmaceutical composition
JPS5233663A (en) Preparation of novel 2*22 dimethylsteroid and pharmaceutical composition